Welcome to Mountain Peaks

Kratom to be Classified as Schedule 1 Drug

Mountain Peaks IncDrug Testing Kratom to be Classified as Schedule 1 Drug

Kratom to be Classified as Schedule 1 Drug

via DATIA – The Administrator of the Drug Enforcement Administration (DEA) is issued a notice of intent on Aug. 31, 2016 to temporarily schedule the opioids mitragynine and 7- hydroxymitragynine, which are the main active constituents of the plant kratom, into schedule I pursuant to the temporary scheduling provisions of the Controlled Substances Act.

Kratom, which contains the main active alkaloids mitragynine and 7- hydroxymitragynine, has a long history of use in Southeast Asia as an opium substitute. Kratom is also known in Southeast Asia as thang, thom, krathom, kakuam, ketum, and biak. In recent years, the presence of the psychoactive plant kratom has increased dramatically on the recreational market in the United States due to its opioid-like effects. Numerous vendors selling kratom have appeared in the past few years, markedly increasing its availability. Kratom preparations, which contain the main active alkaloids mitragynine and 7-hydroxymitragynine, are easily obtained from smoke shops and over the Internet. The Internet is the most utilized source for the purchase of kratom products, making kratom just ‘‘a click’’ away for users. In the United States, law enforcement has seized kratom/mitragynine products in the following forms: powder/plant, powder, plant or vegetable material, capsules, tablets, liquids, gum/resin, and drug patch.

Read the full Aug. 31 Federal Register.

UPDATE – Public Comment will be taken through November 2016 prior to enacting this regulation

No Comments

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.